Assessment of the Clinical Effectiveness of Dolutegravir-based Antiretroviral  Therapy Among Adults Living With HIV at the Kenyatta National  Hospital

dc.contributor.author	Shiundu, Kevin A
dc.date.accessioned	2022-05-18T07:55:55Z
dc.date.available	2022-05-18T07:55:55Z
dc.date.issued	2021
dc.identifier.uri	http://erepository.uonbi.ac.ke/handle/11295/160726
dc.description.abstract	Background: Dolutegravir is highly effective, with a high genetic barrier to HIV grug resistance , and is well tolerated. International studies have assessed the efficacy and non-inferiority of dolutegravir, but more studies are required to assess its clinical effectiveness in resource-constrained settings………………. …………………………………………………………………………………………………………………………………………………………………	en_US
dc.language.iso	en	en_US
dc.publisher	University of Nairobi	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	Clinical Effectiveness, Dolutegravir-based Antiretroviral Therapy, Adults Living With HIV, Kenyatta National Hospital	en_US
dc.title	Assessment of the Clinical Effectiveness of Dolutegravir-based Antiretroviral Therapy Among Adults Living With HIV at the Kenyatta National Hospital	en_US
dc.type	Thesis	en_US
dc.description.department	a Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine, Moi University, Eldoret, Kenya

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States